Skip to content

Effect of intravenous lidocaine on propofol Schnider mode TCI inhibition of cervical dilatation during induced abortion

Effect of intravenous lidocaine on propofol Schnider mode TCI inhibition of cervical dilatation during induced abortion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074470
Enrollment
Unknown
Registered
2023-08-08
Start date
2023-08-17
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for patients undergoing painless induced abortion

Interventions

lidocaine group:Intravenous injection of lidocaine 1mg/kg

Sponsors

Shunde Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients with primary induced abortion, 6-9 weeks gestation, age =35 years old, body mass index 18-25 kg/m2, ASA grade I-? were selected.

Exclusion criteria

Exclusion criteria: Potential difficult airway (cervical disease, grade 3 or 4 Mahalanobis, mouth opening less than 2.5CM); Severe hepatic and renal insufficiency; Serious cardiovascular and respiratory diseases; Neurological diseases; Effects of preoperative use of sedatives, antidepressants and other drugs; Allergic or contraindicated to the drug being tested.

Design outcomes

Primary

MeasureTime frame
Propofol's EC50;

Secondary

MeasureTime frame
Vital signs;Wake up of time;The operation time;Pain of propofol injection;VAS pain score;

Countries

China

Contacts

Public ContactWang Guanhua

Shunde Hospital, Southern Medical University

crownchina@163.com+86 131 8963 2255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026